Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research Progress of Platinum-Based Anticancer Drugs in Combination with Macrocyclic Drug Delivery System.

Macromolecular rapid communications·2026
Same author

Adaptive Spo11 RNA editing gate optimizes meiosis I pace and mitotic proliferation while preserving ascospore formation.

Science advances·2026
Same author

Beyond gene duplication: A-to-I RNA editing-mediated stop codon readthrough modulates Dbf2 dosage to resolve pleiotropic conflicts.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Development of a Reverse Transcription Recombinase Polymerase Amplification CRISPR/Cas12a Assay for Visual and Highly Specific Identification of Zika Virus.

Journal of medical virology·2026
Same author

Exploring Metabolic Changes in Children with Congenital Hypothyroidism: A Serum Metabolomic Study Combined by Machine Learning.

Journal of proteome research·2026
Same author

Editorial: Ferroptosis, cuproptosis, and triaptosis: unveiling pathways and translational prospects.

Frontiers in cell and developmental biology·2026

Related Experiment Video

Updated: Mar 6, 2026

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
05:51

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

Published on: March 17, 2023

2.4K

Near-Infrared-Absorbing Donor-Acceptor Ru(II) Complexes as High-Performance Photothermal Agents for Cancer Therapy.

Junqi Huang1, Zhiwei Xu2, Pengmin Shi3

  • 1School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Inorganic Chemistry
|March 4, 2026
PubMed
Summary

Researchers developed novel Ruthenium(II) polypyridyl complexes for photothermal therapy (PTT). RuDA2 demonstrated superior near-infrared absorption and photothermal conversion efficiency, leading to potent cancer cell killing via mitochondrial targeting.

More Related Videos

Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
06:42

Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution

Published on: May 9, 2025

1.2K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.6K

Related Experiment Videos

Last Updated: Mar 6, 2026

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
05:51

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

Published on: March 17, 2023

2.4K
Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
06:42

Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution

Published on: May 9, 2025

1.2K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.6K

Area of Science:

  • Materials Science
  • Chemistry
  • Biomedical Engineering

Background:

  • Metal-based compounds show promise in cancer therapy and diagnostics.
  • Limited exploration of metal complexes in photothermal therapy (PTT) due to unfavorable photophysical properties.

Purpose of the Study:

  • Design and synthesize novel Ruthenium(II) polypyridyl complexes for PTT.
  • Investigate their photophysical properties and in vitro efficacy.

Main Methods:

  • Synthesis of two Ru(II) polypyridyl complexes (RuDA1 and RuDA2) with narrow-band-gap ligands.
  • Photophysical characterization including absorption and aggregation studies.
  • In vitro cytotoxicity assays and mechanism investigation (mitochondrial targeting).

Main Results:

  • Both complexes absorbed in the near-infrared (NIR) region, with redshift upon aggregation.
  • RuDA2 exhibited enhanced nonradiative decay and a superior photothermal conversion efficiency (51.3%) compared to RuDA1 (39.3%).
  • Both complexes showed potent photothermal cytotoxicity; RuDA2 was particularly effective via mitochondrial targeting.

Conclusions:

  • Rationally designed NIR-absorbing Ru(II) polypyridyl complexes can serve as effective photothermal agents (PTAs).
  • Structural modifications, like incorporating thiophene bridges, can optimize photothermal conversion efficiency.
  • RuDA2 represents a promising candidate for advancing photothermal cancer therapy.